Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification.
Ferro M, Rocco B, Maggi M, Lucarelli G, Falagario UG, Del Giudice F, Crocetto F, Barone B, La Civita E, Lasorsa F, Brescia A, Catellani M, Busetto GM, Tataru OS, Terracciano D.
Ferro M, et al. Among authors: catellani m.
Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1061-1070. doi: 10.1080/14737159.2023.2277366. Epub 2023 Dec 15.
Expert Rev Mol Diagn. 2023.
PMID: 37897252
Review.